National Institutes of Health IDeA Program

FY16 AppropriationFY17 Budget RequestFY17 Coalition Goal
$273.325m$320.84m$331.136m*

*1% of total NIH budget

OBJECTIVE: Continue to support funding for NIH IDeA in the FY 2017 Appropriations Bill and propose that the IDeA program budget be at least 1% of total NIH funding.

BACKGROUND

  • The National Institutes of Health (NIH) Institutional Development Award (IDeA) program increases our nation’s biomedical research capability by improving research in states that have historically been less successful in obtaining biomedical research funds.  IDeA funds only merit-based, peer-reviewed research that meets NIH research objectives in the 23 IDeA states and Puerto Rico. The FY 2017 Budget Justification for the National Institute of General Medical Sciences (NIGMS) praised the IDeA program for its dramatic impact on students, researchers, and institutions.
  • NIH IDeA is comprised of these key initiatives:  
    • Centers of Biomedical Research Excellence (COBRE);
    • IDEA Networks of Biomedical Research Excellence (INBRE); and,
    • IDeA Clinical and Translational Program Awards (IDeA-CTR).
  • The COBRE program increases the number of well-trained investigators in IDeA states by expanding research facilities, equipping laboratories with the latest research equipment, providing mentoring for promising investigators, and developing research faculty through support of a targeted multi-disciplinary center, led by an established, senior investigator with expertise in the research focus area of the center.  The FY17 NIGMS budget justification pointed out a recent study of a COBRE program that showed that COBRE-funded junior investigators were three times more likely to have career success than a matched group of investigators who did not participate in the program.
  • INBRE increases the pipeline of outstanding students and enhances the quality of science faculty in the IDeA states by research intensive networking at undergraduate institutions.  The INBRE program supports research infrastructure and mentoring of young investigators, and prepares students for graduate and professional schools as well as careers in the biomedical sciences at participating institutions. 
  • The IDeA-CTR program encourages applications from IDeA states to develop infrastructure for clinical and translational research.

NATIONAL BENEFITS

  • Despite the small portion of NIH funding, IDeA has been highly successful in increasing the competitiveness of researchers and research and academic institutions in IDeA states. Measures of success include: $1.415 billion in NIH funding awarded to IDeA state investigators in FY 2014; breakthroughs in post-traumatic stress disorder, asthma, stroke, dementia, multiple sclerosis, cancer, and many other diseases that affect human health.
  • Roughly 20% of the Nation’s population live in EPSCoR/IDeA states, yet in FY 1999, the year before COBRE grants were initiated, the 23 IDeA states and Puerto Rico received a total of $596 million in NIH funding. In FY 2014, these entities received $1.415 billion, a 2.4-fold increase. Citizens from all states should have the opportunity to benefit from the latest innovations in biomedical research and health care. 

REGIONAL BENEFITS

  • The IDeA program allows more states to participate in NIH’s biomedical research enterprise, enhances research capacity and competitiveness by strengthening the biomedical research infrastructure in the IDeA states, mentors scientists and students, and builds a skilled biomedical workforce capable of meeting global challenges.
  • The IDeA program enables more researchers from the IDeA states to be competitive for mainstream NIH funding such as R01 grants and ensures that more students pursue careers in biomedical research, in medical fields or other health related professions.   
ex arrow-right check news twitter facebook